Andrej Janež

Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)

Matthew Capehorn, Andrei‐Mircea Catarig, Julie Kjærulff Furberg et al. · Diabetes & Metabolism · 2019 · 407 citations

Medicine, Pharmacology, Pharmacotherapy +16

Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment

Julio Rosenstock, Harpreet S. Bajaj, Andrej Janež et al. · New England Journal of Medicine · 2020 · 205 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study

Vesna Šalamun, Mojca Jensterle, Andrej Janež et al. · European Journal of Endocrinology · 2018 · 190 citations

Medicine, Endocrinology, Gynecology +14

Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin

Mojca Jensterle, Tomaž Kocjan, Marija Pfeifer et al. · European Journal of Endocrinology · 2013 · 169 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes

Guntram Schernthaner, Naim Shehadeh, Anna Bazarova et al. · Cardiovascular Diabetology · 2020 · 160 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17